The Lancet

NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus ...

aDepartment of Surgery, Institut Curie, PSL Research University, Paris, France bDepartment of Radiation Therapy, Institut Curie, PSL Research University, Paris, France cDepartment of Radiology, ...